This inventor holds 1 USPTO granted patent. Top assignee: Kgk Synergize, Inc.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Kenneth Kitchener Carroll: Innovator in Neoplastic Disease Treatment
Introduction
Kenneth Kitchener Carroll is a notable inventor based in London, Canada. He has made significant contributions to the field of medical treatments, particularly in addressing neoplastic diseases and hypercholesterolemia. His innovative approach combines natural compounds to create effective treatment methods.
Latest Patents
Kenneth Carroll holds a patent for "Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols." This patent describes compositions and methods aimed at preventing and treating neoplastic diseases and hypercholesterolemia. The invention focuses on individuals at high risk of developing these conditions, offering a treatment option that utilizes triterpene derivatives found in citrus limonoids, polyphenolic flavonoid citrus compounds, tocotrienols, or a combination of these agents.
Career Highlights
Carroll is associated with Kgk Synergize, Inc., where he continues to develop and refine his innovative treatments. His work has the potential to impact many lives by providing alternative therapeutic options for patients facing serious health challenges.
Collaborations
Some of his notable coworkers include Najla Guthrie and Elzbieta Maria Kurowska. Their collaborative efforts contribute to the advancement of research and development in the field of health and wellness.
Conclusion
Kenneth Kitchener Carroll is a pioneering inventor whose work in the treatment of neoplastic diseases and hypercholesterolemia showcases the potential of natural compounds in medicine. His contributions are paving the way for innovative solutions in healthcare.